Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - February 2014


4th Annual Pharma R&D Asia Congress 2014

27 Feb 2014 - 28 Feb 2014 - Shanghai, China



Bookmark and Share


The booming growth of research and development activities in Asia and Asia Pacific regions has advanced the opportunity for business success. Industry leaders believe that the Asian market will overtake the US by 2020. Our conference will bring together industry leaders to discuss the potential and future of the R&D industry. Our exclusive networking sessions will offer opportunities to meet with potential partners and form unique business relationships.

Expert speakers will discuss strategies to advance research and development activities in Asia. They will offer insights into the importance of collaborations between eastern and western countries for advancing global drug development. Topics will also cover methods to choose correct outsourcing partners for business needs, attaining successful mergers and acquisitions and opportunities for multi-national companies in emerging markets.

Confirmed Speakers Include:

·         Yariv Hefez, VP, Merck, Switzerland

·         Beverly Lui, Director, Amgen, China

·         Jian Li, Director, Global R&D Sanofi, China

·         Yuan-Hua Ding, Senior Director, Pfizer Worldwide R&D, USA

·         Simon McErlane, Senior Medical, Takeda Development Center Asia, Singapore

 To view full list of speakers, click here.

The event will provide the opportunity for networking and knowledge sharing in the expanding clinical market in Asia and Asia Pacific regions. Over the two days the event will attract over 150 senior-level international decision makers working in discovery, R&D, translational sciences, medical affairs and outsourcing & partnerships from pharma and biotech companies in Asia, Australia, the USA and Europe.

To download agenda, please click here.


Please contact Freda Shi at +65 6570 2208 or email f.shi@oxfordglobalasia.com to express your interest today!



Further information
Scientific News
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Study Uncovers Target for Preventing Huntington’s Disease
Scientists from Cardiff University believe that a treatment to prevent or delay the symptoms of Huntington’s disease could now be much closer, following a major breakthrough.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!